Pactiv Evergreen Shareholders Receive Final Payout as Acquisition Closes

The publicly traded journey of Pactiv Evergreen has concluded following the finalization of its acquisition by Novolex Holdings. The deal, valued at a total of $6.7 billion, was completed on April 1, 2025, resulting in a payment of $18 per share to stockholders and the immediate delisting of the company’s shares from the Nasdaq exchange.

Novolex Holdings secured Pactiv Evergreen for $18 per common share, a price that represents a substantial 49% premium over the stock’s two-month volume-weighted average price prior to the public announcement of the transaction. The comprehensive $6.7 billion transaction volume includes the assumption of Pactiv Evergreen’s net debt.

The acquisition process, which was initiated in December 2024, moved swiftly through Read more...